Annual Current Liabilities
$163.78 M
+$84.90 M+107.62%
31 December 2023
Summary:
Harmony Biosciences Holdings annual total current liabilities is currently $163.78 million, with the most recent change of +$84.90 million (+107.62%) on 31 December 2023. During the last 3 years, it has risen by +$29.24 million (+21.73%). HRMY annual current liabilities is now at all-time high.HRMY Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$161.28 M
+$14.70 M+10.03%
30 September 2024
Summary:
Harmony Biosciences Holdings quarterly total current liabilities is currently $161.28 million, with the most recent change of +$14.70 million (+10.03%) on 30 September 2024. Over the past year, it has increased by +$48.87 million (+43.48%). HRMY quarterly current liabilities is now -1.53% below its all-time high of $163.78 million, reached on 31 December 2023.HRMY Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HRMY Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +107.6% | +43.5% |
| 3 y3 years | +21.7% | +238.7% |
| 5 y5 years | +2165.0% | - |
HRMY Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +204.6% | -1.5% | +238.7% |
| 5 y | 5 years | at high | +2165.0% | -1.5% | +880.2% |
| alltime | all time | at high | +2165.0% | -1.5% | +880.2% |
Harmony Biosciences Holdings Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $161.28 M(+10.0%) |
| June 2024 | - | $146.58 M(-5.0%) |
| Mar 2024 | - | $154.25 M(-5.8%) |
| Dec 2023 | $163.78 M(+107.6%) | $163.78 M(+45.7%) |
| Sept 2023 | - | $112.41 M(+20.8%) |
| June 2023 | - | $93.05 M(+9.0%) |
| Mar 2023 | - | $85.36 M(+8.2%) |
| Dec 2022 | $78.88 M | $78.88 M(-26.5%) |
| Sept 2022 | - | $107.36 M(+63.2%) |
| June 2022 | - | $65.76 M(+16.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $56.53 M(+5.1%) |
| Dec 2021 | $53.77 M(-60.0%) | $53.77 M(+12.9%) |
| Sept 2021 | - | $47.62 M(+30.1%) |
| June 2021 | - | $36.59 M(+9.4%) |
| Mar 2021 | - | $33.44 M(-75.1%) |
| Dec 2020 | $134.54 M(+576.3%) | $134.54 M(+323.2%) |
| Sept 2020 | - | $31.79 M(+50.9%) |
| June 2020 | - | $21.06 M(+28.0%) |
| Mar 2020 | - | $16.45 M(-17.3%) |
| Dec 2019 | $19.89 M(+175.1%) | $19.89 M |
| Dec 2018 | $7.23 M | - |
FAQ
- What is Harmony Biosciences Holdings annual total current liabilities?
- What is the all time high annual current liabilities for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings annual current liabilities year-on-year change?
- What is Harmony Biosciences Holdings quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings quarterly current liabilities year-on-year change?
What is Harmony Biosciences Holdings annual total current liabilities?
The current annual current liabilities of HRMY is $163.78 M
What is the all time high annual current liabilities for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high annual total current liabilities is $163.78 M
What is Harmony Biosciences Holdings annual current liabilities year-on-year change?
Over the past year, HRMY annual total current liabilities has changed by +$84.90 M (+107.62%)
What is Harmony Biosciences Holdings quarterly total current liabilities?
The current quarterly current liabilities of HRMY is $161.28 M
What is the all time high quarterly current liabilities for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high quarterly total current liabilities is $163.78 M
What is Harmony Biosciences Holdings quarterly current liabilities year-on-year change?
Over the past year, HRMY quarterly total current liabilities has changed by +$48.87 M (+43.48%)